TYRX to exhibit AIGISRx Anti-Bacterial Envelope at HFSA

NewsGuard 100/100 Score
Sep 14 2009

TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, announced today that it will be exhibiting its lead product, AIGISRx™ Anti-Bacterial Envelope, at the 13th Annual Heart Failure Society of America Meeting (HFSA), in Boston, MA this week.

The Heart Failure Society of America, Inc. (HFSA) brings together heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care.

AIGISRx is an anti-bacterial mesh envelope developed to deliver anti-microbial agents that help provide protection against infections associated with implanted pacemakers and cardioverter defibrillators. AIGISRx also securely holds a pacemaker (PM) or implantable cardioverter defibrillator (ICD) in order to create a stable environment when implanted in the body.

SOURCE: TYRX, Inc.

Posted in: Device / Technology News

Tags: , , , , , , , , ,

Comments (0)

Suggested Reading

Research reveals undertreatment of women with heart disease
American Heart Association funds four new projects to evaluate the role of race in predicting heart disease risk
Study suggests a common brain network exists between heart rate deceleration and depression
Research identifies a unique protein fingerprint linked to very short sleep and increased diabetes risk
National study links air pollution to increased risk of heart attacks in Poland
Atrial fibrillation linked to high mortality and hospitalization rates, UQ study shows
NYU Langone surgeons perform first combined mechanical heart pump and gene-edited pig kidney transplant surgery
Sedentary behavior and low activity levels in childhood linked to heart strain in adolescence

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Study shows link between air pollution, stress, and heart health risk